Business Daily from THE HINDU group of publications
Wednesday, Sep 20, 2006

Cross Currency

Group Sites

Corporate - Alliances & Joint Ventures
Arch Pharma signs pact with Apex Drugs

Our Bureau

Hyderabad , Sept. 19

Arch Pharmalabs Ltd, a Mumbai-based company engaged in the manufacture of active pharmaceutical ingredients (APIs) and intermediates, has announced a co-marketing alliance with Apex Drugs & Intermediates Ltd, a Hyderabad-based company into APIs.

In a press release here, the Arch Pharmalabs Director, Mr V. Balaji, termed it as a new business model that the company is continuing to nurture. The company has been looking at such opportunities to help it expand its product and capabilities through partners thus exploring and banking on respective strengths in the manufacturing and marketing and offer the customers a single source for various products in various therapeutic segments, he said.

Apex Drugs said its association with Arch takes it to hitherto untapped markets.

Arch Pharmalabs said the Apex portfolio would help it to enter into the anti ulcerants, anti histamine and other therapeutic segments. It expects the pool of assets at Apex to aid it in restructuring the company's manufacturing and backward integration strategy.

Further, the Rs 250-crore Mumbai-based company said it is confident of similar alliances besides its organic growth strategy to help it consolidate its position in the CMO space in the pharma world.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Rajasthan refinery not viable: ONGC

ONGC to pay 200 pc final dividend, issue 1:2 bonus in Nov
IOC starts commercial despatch of PTA
Welspun bags orders worth Rs 700 cr
Praj Ind buys US engineering co for Rs 22.5 cr
McLeod Russel open to more acquisitions in Assam
Azim Premji picks up 2-lakh shares of Birla Corp
Elder Pharma plans JV in Ghana
Glenmark gets US nod for nausea drug
Mother Dairy to set up bourse for farm produce
Arch Pharma signs pact with Apex Drugs
Serum Institute signs pact with Akorn
Chemtech move to standardise research, trial practices
Free dental check-ups
Nilkamal Plastics to enter realty biz
Matex Net to e-auction Standard Motors' assets
No immediate challenge from China: Sun Pharma
NTPC plans to treble capacity to 75,000 MW by 2017
Aurobindo Pharma bets on low-cost strengths
United Breweries raises borrowing limit to Rs 1,500 cr
STC posts Rs 3,000-cr turnover in Apr-Aug

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line